Tumors can be resistant due to a single or a combination of biological determining factors, involving intrinsic factors such as tumor burden and growth kinetics, tumor heterogeneity, physical barriers, tumor microenvironment, and undruggable genomic drivers (e.g., c-MYC and TP53), and extrinsic factors such as selective therapeutic pressure. This evidence concerns the gene TP53 and neoplasm.